British pharmaceutical giant Shire PLC yesterday warned that plans for a major drug manufacturing complex in Boston’s suburbs could be in jeopardy unless Beacon Hill passes a trumpeted, $1 billion incentive package for the life sciences industry.
British pharmaceutical giant Shire PLC yesterday warned that plans for a major drug manufacturing complex in Boston’s suburbs could be in jeopardy unless Beacon Hill passes a trumpeted, $1 billion incentive package for the life sciences industry.
